CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Tilray cannabis sees share price fall amid higher losses

By William Hoffman

14:15, 7 October 2021

Tilray cannabis investors continue to worry
Tilray cannabis investors continue to worry - Photo: Shutterstock

Canadian cannabis company Tilray reported revenue and gross profit growth during its latest quarterly earnings report on Thursday, but investors continue to worry about its net losses.

Tilray posted net revenue of $168m (£123.3m) for the three-month period ending in August, up 43% over the comparable period from last year, according to the company’s press release. Those strong revenue numbers drove another profitable quarter of $51m in gross profit, up 46% year over year.

However, net losses totalled $34.6m during the quarter compared with net losses of $21.7m in the prior year quarter. It also represented a reversal of the net income gain of $33.6m the company posted in its prior quarterly results for the three-month period ending in May.  

Stock price

Tilray shares swiftly moved nearly 3% lower to around $10.47 per share as the market absorbed the news.

Tilray’s shares are technically up nearly 20% on the year, but back in February a Reddit retail investor push caused the shares to surge briefly to highs of $67 per share. Since then, the shares have fallen by around 84%.

After the company set a price for its initial public offering at $17 per share in 2018, the shares quickly surged to more than $148 per share in the following months. But since that IPO, Tilray shares have continued to fall and now trade 92% lower off those highs.

Mergers and acquisitions

Tilray has been aggressive in its acquisition strategy since going public and management said it will continue to be aggressive as it looks to expand in Germany and more broadly in Europe.

In May, Tilray closed its acquisition of Aphria making it the largest cannabis company by revenue. To date, the company says that acquisition has helped generate cost-savings of $55m on a run-rate basis, with actual cash-savings close to $20m.


26,563.95 Price
+0.580% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 60.00


1,956.12 Price
+0.810% 1D Chg, %
Long position overnight fee -0.0090%
Short position overnight fee 0.0008%
Overnight fee time 21:00 (UTC)
Spread 0.33

Oil - Crude

73.09 Price
+0.680% 1D Chg, %
Long position overnight fee -0.0156%
Short position overnight fee -0.0063%
Overnight fee time 21:00 (UTC)
Spread 0.03


14,326.90 Price
+0.230% 1D Chg, %
Long position overnight fee -0.0255%
Short position overnight fee 0.0032%
Overnight fee time 21:00 (UTC)
Spread 1.8

Back in November 2020, Tilray also bought Atlanta-based brewery SweetWater, which the company said drove $15m of revenue during the quarter.

Additionally, Tilray’s acquisition of CBD and hemp foods brand Manitoba Harvest from 2019 drove another $15m of revenue for the company during the quarter.

Legalisation efforts

Senate majority leader Chuck Schumer of New York introduced a bill earlier this month to legalise marijuana in the US.

Taking questions from retail investors during the earnings call, one investor described the legislation as “impending”. However, later in the call Vivien Azer of Cowen and Co. noted that the company’s house view is that the legislation is very much not impending. 

Congress currently is focused on passing the Build Back Better Act, a corresponding bipartisan infrastructure bill, and expanding the debt ceiling so that the government does not default on its debts.

“The Schumer bill came out with a lot of thunder, and everyone thought it would happen right away, but I agree with you that it’s slow,” said Irwin Simon, chair and CEO of Tilray. “Yes, we’d love to see legalisation in the US … but if legalisation doesn’t happen for 18-24 months, we still have a lot of runway to grow this business and do acquisitions in adjacent areas whether its spirits and alcohol or hemp and CBD.”

Read more: Tilray stock forecast: can TLRY recover after 80% losses?


Rate this article

Capital Com is an execution-only service provider. The material provided on this website is for information purposes only and should not be understood as an investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page then you do so entirely on your own risk.

Still looking for a broker you can trust?

Join the 535.000+ traders worldwide that chose to trade with

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading